Neos Innovative Pharma Stock for Bargain Investors

Many of the best bargain stocks of the past two years have hit the mainstream, but there’s still plenty of promising companies to find at the entry-point of the market. Innovative pharmaceuticals offer high potential for growth with low stock prices on some of the best companies. Neos Therapeutics Inc. (NASDAQ: NEOS) is one option […]

This Pharmaceutical Company is Ready to Grow

Aileron Therapeutics Inc. (NASDAQ: ALRN) is a bio pharmaceutical company that focuses on the development of novel oncology drugs. The company’s recently developed ALRN-6924 treatment is in Phase 2A clinical trials for the treatment of advanced solid tumors. The company is also developing leukemia treatments which are currently in Phase 1B testing. Analysts have been […]

GW Pharmaceuticals Stock Still Looks Good for Its Upside

GW Pharmaceuticals PLC (OTC: GWPRF) is an innovative pharmaceutical developer that focuses on CBD (cannabidiol) therapies. It was the first company to receive FDA approval for a cannabis-based drug, and it’s close to releasing its second CBD treatment. Low earnings and hesitation during the COVID19 pandemic have left this stock lingering at the bottom of […]

Is Cronos Group Still a Worthy Pot Pick?

Cronos Group Inc. (NASDAQ: CRON) is one of the oldest and most popular cannabis stocks on the market. It has been historically volatile, but some signs indicate that it could move towards stability. Find out if this bargain alternative pick is portfolio-worthy. Cronos, like many of its industry peers, has generated strong revenue growth over […]

Cronos Stock is Showing Signs of Momentum

Marijuana stocks are showing signs of traction, following some strong growth in the market last week. Cronos Group Inc. (NASDAQ: CRON) is a popular pick, and its current momentum will give some inspiration to new investors, or even older pot stock investors looking to expand their portfolios. Over the last five days, Cronos is up […]

Pharmaceutical Marijuana Stock is Heavily Discounted

Floating just above the traditional bargain limit of $10, Cara Therapeutics Inc. (NASDAQ: CARA) is still a cannabis stock to watch this year. This clinical-stage pharmaceutical company is involved in the research, development, and commercialization of novel drug treatments. This stock is interesting because it is diversified beyond the cannabis market. Although the company is […]

This Stock is a Penny Pick for Pot Investors

cbdMD Inc. (NYSE: YCBD) is a producer and distributor of cannabidiol (CBD) products in the United States. It focuses on the consumer health and wellness market with CBD-derived gummies, topical ointments, tinctures, bath products, and pet products. In its Q2 preliminary revenue report, the company advised $9.4 million in revenue, a year over year increase […]

A Pharmaceutical Cannabis Stock with High Potential

In a week where stocks have seen sweeping declines, Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) shares are up 23.65% over the last five days. Analysts are optimistic about this stock and its potential recovery after the current market downturn. It’s a pick worth considering for an alternative portfolio. Zynerba is a pharmaceutical company that focuses on […]

A Bargain Cannabis Stock with Strong Growth Potential

Volume in cannabis stock trading has lagged the market over the last year, but 2020 could see a turnaround. Increasing support for legalization and growing revenues in the medical cannabis sector will benefit some key stocks. Trulieve Cannabis Corp. (OTC: TCNNF) is priced at a bargain today, and there are strong signals suggesting that it […]

Pick Up Aurora Cannabis at a Bargain Price

Cannabis stocks are set for a strong rebound in 2020. After underperforming last year, stock prices now appear to have corrected and many of the best picks have momentum behind them. The ETFMG Alternative Harvest ETF, a major industry benchmark, is up almost 10% in the year to date. This suggests that confidence is growing. […]